Price:
Rs. 6,300.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes: C0265
Frequently Asked Questions (FAQ's):
What does the CEBPA Mutation Detection test include?
This test analyzes the CEBPA gene for single or double mutations associated with AML, providing detailed molecular insights for disease evaluation.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses highly sensitive molecular assays to detect CEBPA mutations from an EDTA blood sample, ensuring precise and clinically meaningful results.
Who should undergo this test?
Patients being evaluated for acute myeloid leukemia or those with confirmed AML who need prognostic stratification may be advised to take this test.
What type of sample is required for the test?
An EDTA anticoagulated blood sample is required to preserve DNA integrity for reliable mutation analysis.
Why is CEBPA mutation status important?
CEBPA mutations carry significant prognostic value in AML and help clinicians tailor treatment strategies based on individual risk profiles.
How reliable are the results from Metropolis Healthcare?
Metropolis Healthcare follows stringent quality controls, validated protocols, and advanced molecular diagnostics to ensure high accuracy and reproducibility.
Do I need to prepare in any special way before giving the blood sample?
No fasting or special preparation is typically needed; however, patients should follow any additional instructions provided by their physician.
How long does it take to receive the test results?
Turnaround time may vary, but Metropolis Healthcare generally provides timely reports to support prompt clinical decision-making.